Vitamins are essential components for specific biological cellular functions.
Endocyte's lead project is the use of the vitamin folate to target and deliver anticancer agents. Researchers from Endocyte, Inc., have developed and patented a new drug delivery system which couples anti-cancer agents to vitamins, transports these conjugates directly into cancer cells, and bypasses normal, healthy cells. Because cancer cells often overexpress special receptors to increase their vitamin uptake, this method can be used to target cancer cells specifically. Endocyte is seeking partners for folate targeted anticancer agents and investment.